Skip to content
lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Grace Therapeutics, Inc.
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
July 28, 2026
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
April 23, 2026
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
April 14, 2026
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
March 19, 2026
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
February 25, 2026
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
February 12, 2026